Webinars, Conferences, and Discussions

In recognition of Childhood Cancer Awareness Month, join us for the next installment of our Subtype Series, exploring Ewing sarcoma from three complementary perspectives: clinical care, emerging research, and the patient and caregiver experience. The discussion will cover how Ewing sarcoma is diagnosed and treated; how Ewing sarcoma biology, biomarkers, disease monitoring, and emerging therapies are shaping the future of treatment; and the experiences of patients and families throughout diagnosis, treatment, recurrence, and survivorship.

View our recorded educational sessions from Education Day, a part of Sarcoma Community Advocacy Weekend in Washington, D.C., held during Sarcoma Awareness Month on July 17, 2026, featuring sessions focused on drug development and advocacy.

Join us for the next installment of our Subtype Series, focused on angiosarcoma, a rare and often aggressive sarcoma that arises from the cells lining blood vessels and lymphatic vessels. This educational webinar will provide an overview of angiosarcoma, including how it is diagnosed, current treatment approaches, emerging research, and clinical trial opportunities. Participants will also learn about ongoing efforts to improve outcomes for patients through collaborative research and patient advocacy initiatives. Our featured speakers are Dr. Silvia Stacchiotti, one of the world’s leading sarcoma medical oncologists and an internationally recognized expert in angiosarcoma from Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy and President of the Italian Sarcoma Group; Dr. Lee Cranmer, Chief of Sarcoma Medical Oncology at City of Hope and a leading expert in sarcoma clinical care and clinical trials; and Dr. Corrie Painter, researcher, patient advocate, and founder of the Angiosarcoma Project.

Join us for the next Live Virtual Session with the Experts! This session will provide an overview of biomarkers, what they are and how they are discovered and validated. During the session we will highlight the different types of biomarker tests used in sarcoma, how results are interpreted, and how this information can guide personalized treatment strategies. As biomarker testing becomes more integrated into patient care, understanding biomarkers and how they can be used in treatment planning can help patients and families better navigate their treatment and clinical trial options. Our expert speakers, Dr. Sandra D’Angelo (Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY) and Dr. Priya Chudasama (Precision Sarcoma Research, German Cancer Research Center, Heidelberg, Germany), will provide both clinical and research perspectives on how biomarker testing is used today and where the field is heading.

We invite you to join us for Part 2 of our educational webinar series on circulating tumor DNA (ctDNA) in sarcomas. Building on our foundational session, An Introduction to ctDNA in Sarcoma, this next installment moves the conversation forward—addressing emerging research, practical considerations, and the real-world questions patients and clinicians are navigating today. Submit any questions you have in advance or use the Q&A feature during the event.

The first of SFA's series on pediatric sarcomas. Hear from top experts and Care Partner and Advocate, Jenny Sage, on treatment, care, and what makes pediatric sarcomas unique.

This session will be an in-depth discussion about circulating tumor DNA (ctDNA) in sarcomas, including what ctDNA is, how it’s being used in oncology, and what current research is revealing about its role in sarcomas. Our Expert Panelists: Dr. David Schulman of Dana Farber Cancer Institute Dr. Herbert Loong of the Chinese University of Hong Kong Dr. Edwin Choy of Massachusetts General Hospital